Logo image of CAN

CANAAN INC (CAN) Stock Fundamental Analysis

USA - NASDAQ:CAN - US1347481020 - ADR

1.8 USD
+0.28 (+18.42%)
Last: 10/14/2025, 10:00:59 PM
2 USD
+0.2 (+11.11%)
Pre-Market: 10/15/2025, 4:50:09 AM
Fundamental Rating

3

Taking everything into account, CAN scores 3 out of 10 in our fundamental rating. CAN was compared to 33 industry peers in the Technology Hardware, Storage & Peripherals industry. CAN has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, CAN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CAN had negative earnings in the past year.
The reported net income has been mixed in the past 5 years: CAN reported negative net income in multiple years.
In multiple years CAN reported negative operating cash flow during the last 5 years.
CAN Yearly Net Income VS EBIT VS OCF VS FCFCAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -44.93%, CAN is not doing good in the industry: 84.85% of the companies in the same industry are doing better.
With a Return On Equity value of -82.10%, CAN is not doing good in the industry: 60.61% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -44.93%
ROE -82.1%
ROIC N/A
ROA(3y)-42.47%
ROA(5y)-22.42%
ROE(3y)-67.02%
ROE(5y)-38.23%
ROIC(3y)N/A
ROIC(5y)N/A
CAN Yearly ROA, ROE, ROICCAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CAN Yearly Profit, Operating, Gross MarginsCAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

CAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CAN has more shares outstanding
Compared to 5 years ago, CAN has more shares outstanding
The debt/assets ratio for CAN is higher compared to a year ago.
CAN Yearly Shares OutstandingCAN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CAN Yearly Total Debt VS Total AssetsCAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

CAN has an Altman-Z score of 0.56. This is a bad value and indicates that CAN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.56, CAN is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CAN has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
CAN has a better Debt to Equity ratio (0.06) than 69.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACCN/A
WACC8.6%
CAN Yearly LT Debt VS Equity VS FCFCAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

CAN has a Current Ratio of 1.78. This is a normal value and indicates that CAN is financially healthy and should not expect problems in meeting its short term obligations.
CAN has a Current ratio of 1.78. This is in the better half of the industry: CAN outperforms 66.67% of its industry peers.
A Quick Ratio of 1.32 indicates that CAN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.32, CAN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.32
CAN Yearly Current Assets VS Current LiabilitesCAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for CAN have decreased strongly by -90.08% in the last year.
Looking at the last year, CAN shows a very strong growth in Revenue. The Revenue has grown by 82.69%.
CAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.48% yearly.
EPS 1Y (TTM)-90.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1700%
Revenue 1Y (TTM)82.69%
Revenue growth 3Y-29.66%
Revenue growth 5Y5.48%
Sales Q2Q%39.45%

3.2 Future

The Earnings Per Share is expected to grow by 59.58% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 63.16% on average over the next years. This is a very strong growth
EPS Next Y-109.87%
EPS Next 2Y59.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year79.31%
Revenue Next 2Y63.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CAN Yearly Revenue VS EstimatesCAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
CAN Yearly EPS VS EstimatesCAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CAN. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 7.13 indicates a rather cheap valuation of CAN.
87.88% of the companies in the same industry are more expensive than CAN, based on the Price/Forward Earnings ratio.
CAN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 7.13
CAN Price Earnings VS Forward Price EarningsCAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAN Per share dataCAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

CAN's earnings are expected to grow with 59.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.58%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANAAN INC

NASDAQ:CAN (10/14/2025, 10:00:59 PM)

Premarket: 2 +0.2 (+11.11%)

1.8

+0.28 (+18.42%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-18 2025-11-18
Inst Owners18.17%
Inst Owner Change0.06%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap828.65M
Analysts80
Price Target2.53 (40.56%)
Short Float %155.89%
Short Ratio1.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1530.64%
Min EPS beat(2)-2626.58%
Max EPS beat(2)-434.71%
EPS beat(4)1
Avg EPS beat(4)-855.04%
Min EPS beat(4)-2626.58%
Max EPS beat(4)75.8%
EPS beat(8)3
Avg EPS beat(8)-445.81%
EPS beat(12)4
Avg EPS beat(12)-312.22%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.61%
Min Revenue beat(2)-9.04%
Max Revenue beat(2)-8.17%
Revenue beat(4)2
Avg Revenue beat(4)-3.71%
Min Revenue beat(4)-9.04%
Max Revenue beat(4)2.33%
Revenue beat(8)6
Avg Revenue beat(8)11.01%
Revenue beat(12)7
Avg Revenue beat(12)6.12%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.15%
EPS NQ rev (1m)49.93%
EPS NQ rev (3m)108.33%
EPS NY rev (1m)-69.01%
EPS NY rev (3m)21.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-18.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-17.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.13
P/S 2.39
P/FCF N/A
P/OCF N/A
P/B 2.57
P/tB 3.19
EV/EBITDA N/A
EPS(TTM)-2.26
EYN/A
EPS(NY)0.25
Fwd EY14.03%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.75
BVpS0.7
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.93%
ROE -82.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.47%
ROA(5y)-22.42%
ROE(3y)-67.02%
ROE(5y)-38.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.32
Altman-Z 0.56
F-ScoreN/A
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)38.45%
Cap/Depr(5y)94.83%
Cap/Sales(3y)3.6%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-90.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1700%
EPS Next Y-109.87%
EPS Next 2Y59.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)82.69%
Revenue growth 3Y-29.66%
Revenue growth 5Y5.48%
Sales Q2Q%39.45%
Revenue Next Year79.31%
Revenue Next 2Y63.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year115.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.48%
OCF growth 3YN/A
OCF growth 5YN/A